Solved

-Prime Pharmaceuticals Has Developed a New Asthma Medicine, for Which

Question 298

Multiple Choice

  -Prime Pharmaceuticals has developed a new asthma medicine, for which it has a patent. An inhaler can be produced at a constant marginal cost of $2/inhaler. The demand curve, marginal revenue curve, and marginal cost curve for this new asthma inhaler are in the figure above. With its patent giving it a monopoly for its new inhaler, if there is competitive rent seeking, then Prime Pharmaceuticals' producer surplus is equal to A)  $32 million. B)  $48 million. C)  zero. D)  $64 million.
-Prime Pharmaceuticals has developed a new asthma medicine, for which it has a patent. An inhaler can be produced at a constant marginal cost of $2/inhaler. The demand curve, marginal revenue curve, and marginal cost curve for this new asthma inhaler are in the figure above. With its patent giving it a monopoly for its new inhaler, if there is competitive rent seeking, then Prime Pharmaceuticals' producer surplus is equal to


A) $32 million.
B) $48 million.
C) zero.
D) $64 million.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions